U.S. drug manufacturers with products in late-stage clinical trials and on the path to FDA approval may be overlooking an important consideration: preparing for serialization. Starting this November, ...
HILLSBOROUGH, N.J., July 16, 2018 /PRNewswire/ -- Pharmaceutical companies today for the first time have an open source alternative for level 4 serialization with the launch of QU4RTET, a platform ...
Pharmaceutical counterfeiting is on the rise – and a growing health and safety issue with deep consequences for consumers and manufacturers alike. A number of factors contribute to counterfeiting, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results